{"version":"1.0","provider_name":"Hospital Ribera Povisa","provider_url":"https:\/\/riberasalud.com\/povisa","author_name":"comunicacion","author_url":"https:\/\/riberasalud.com\/povisa\/author\/comunicacion\/","title":"\u25b7 De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d | Hospital Ribera Povisa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"hEsSVdeBXu\"><a href=\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/\">De la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/riberasalud.com\/povisa\/faro-vigo-de-la-fuente-monoclonales\/embed\/#?secret=hEsSVdeBXu\" width=\"600\" height=\"338\" title=\"\u00abDe la Fuente en Faro de Vigo: \u201cLos anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\u201d\u00bb \u2014 Hospital Ribera Povisa\" data-secret=\"hEsSVdeBXu\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/riberasalud.com\/povisa\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"lll\u1405 \u201cLos f\u00e1rmacos monoclonales reducen hasta en un ochenta por ciento los ingresos de los pacientes con riesgo de desarrollar un cuadro grave si se administra \u2705 \"Los anticuerpos monoclonales reducen la necesidad de hospitalizaci\u00f3n y UCI\", ha contado el Dr. De la Fuente en Faro de Vigo","thumbnail_url":"https:\/\/riberasalud.com\/povisa\/wp-content\/uploads\/2021\/12\/Captura-de-pantalla-2021-12-27-a-las-11.12.24-806x1024.png"}